IP Library › Granted Patent US 7,879,869
Granted Patent B2
US 7,879,869 · App. 10/485,217 · Granted Feb 1, 2011

Drugs for ameliorating postcibal hyperglycemia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,869
App. No.
10/485,217
Granted
Feb 1, 2011
Kind
B2
Abstract

It is mentioned to provide drugs for ameliorating postcibal hyperglycemia, drugs for inhibiting an increase in blood glucose level and pharmaceutical compositions for preventing or treating diabetes, each containing a pharmaceutically acceptable anion exchange resin typified by colestimide. Thus, it becomes possible to provide drugs clearly exhibiting an effect of inhibiting an increase in postcibal blood glucose level.

Claims (2)

1. A method for ameliorating postcibal hyperglycemia consisting of administering a therapeutically effective amount of colestimide as the active ingredient to a patient in need thereof.

2. A method for inhibiting an increase in postcibal blood glucose level, consisting of administering a therapeutically effective amount of colestimide as the active ingredient to a patient in need thereof.

Assignments (3)
CHANGE OF ADDRESS Recorded Dec 17, 2010
From: MITSUBISHI TANABE PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 025523/0517 →
CHANGE OF NAME Recorded Apr 17, 2008
From: MITSUBISHI PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020838/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2004
From: OBA, KENZO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 015039/0406 →